GMP certified Reniale® production possible
The Dutch Healthcare Inspectorate (IGZ) and Farmatec/CIBG granted EMCM, a Leader Biomedical Group company, GMP certification.
Along with the GMP certification, EMCM also received the manufacturing authorisation to produce Reniale®, a medicine used in the treatment of cancer. With this successful audit, EMCM has demonstrated that it is able to aseptically process human derived products.
EMCM achieved this milestone in partnership with VCC Medical N.V., a full daughter company of Vaccentis AG in Zurich, Switzerland.
For more information, please see the original article on the EMCM website.